BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Erickson S, Nahmias Z, Rosman IS, Kim BS. Immunomodulating Agents as Antipruritics. Dermatologic Clinics 2018;36:325-34. [DOI: 10.1016/j.det.2018.02.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Trier AM, Mack MR, Kim BS. The Neuroimmune Axis in Skin Sensation, Inflammation, and Immunity. J Immunol 2019;202:2829-35. [PMID: 31061146 DOI: 10.4049/jimmunol.1801473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
2 Meixiong J, Anderson M, Limjunyawong N, Sabbagh MF, Hu E, Mack MR, Oetjen LK, Wang F, Kim BS, Dong X. Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch. Immunity 2019;50:1163-1171.e5. [PMID: 31027996 DOI: 10.1016/j.immuni.2019.03.013] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 25.7] [Reference Citation Analysis]
3 Labib A, Ju T, Vander Does A, Yosipovitch G. Immunotargets and Therapy for Prurigo Nodularis. ITT 2022;Volume 11:11-21. [DOI: 10.2147/itt.s316602] [Reference Citation Analysis]
4 Fourzali KM, Yosipovitch G. Management of Itch in the Elderly: A Review. Dermatol Ther (Heidelb) 2019;9:639-53. [PMID: 31549284 DOI: 10.1007/s13555-019-00326-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Yavuz C. Biologics in dermatology: What does the future hold? Dermatol Ther 2019;32:e12932. [PMID: 30977240 DOI: 10.1111/dth.12932] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Wang Z, Babina M. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis? Exp Dermatol 2020;29:1104-11. [PMID: 32866307 DOI: 10.1111/exd.14182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
7 Yang TB, Kim BS. Pruritus in allergy and immunology. J Allergy Clin Immunol 2019;144:353-60. [PMID: 31395149 DOI: 10.1016/j.jaci.2019.06.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
8 Abreu D, Kim BS. Innate Immune Regulation of Dermatitis. Immunol Allergy Clin North Am 2021;41:347-59. [PMID: 34225893 DOI: 10.1016/j.iac.2021.04.011] [Reference Citation Analysis]
9 Wang F, Kim BS. Itch: A Paradigm of Neuroimmune Crosstalk. Immunity 2020;52:753-66. [PMID: 32433948 DOI: 10.1016/j.immuni.2020.04.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
10 Inan S, Torres-Huerta A, Jensen LE, Dun NJ, Cowan A. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. Eur J Pharmacol 2019;864:172702. [PMID: 31568781 DOI: 10.1016/j.ejphar.2019.172702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
11 Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther 2021;222:107784. [PMID: 33316286 DOI: 10.1016/j.pharmthera.2020.107784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Misery L, Belloni Fortina A, El Hachem M, Chernyshov P, Kobyletzki L, Heratizadeh A, Marcoux D, Aoki V, Zaniboni M, Stalder J, Eichenfield L. A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient‐Education Network in Dermatology (OPENED) task force. J Eur Acad Dermatol Venereol 2021;35:787-96. [DOI: 10.1111/jdv.16916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
13 Müller S, Bieber T, Ständer S. Therapeutic potential of biologics in prurigo nodularis. Expert Opin Biol Ther 2021;:1-12. [PMID: 34289753 DOI: 10.1080/14712598.2021.1958777] [Reference Citation Analysis]